The global cardiac biomarkers testing market was valued at $9,766.93 million in 2020, and is projected to reach $28,098.07 million by 2030, registering a CAGR of 10.9% from 2021 to 2030.
Report Code : A04921 | Pages : 235 | Category : Life Sciences
The global cardiac surgical devices market was valued at $2.2 billion in 2020, and is projected to reach $3.1 billion by 2030, growing at a CAGR of 3.3% from 2021 to 2030.
Report Code : A01847 | Pages : 193 | Category : Life Sciences
Global Cardiac Monitoring & Cardiac Rhythm Management Market size was valued at $19,397 million in 2015 and is expected to reach $32,216 million by 2022, growing at a ...
Report Code : A01492 | Pages : 318 | Category : Life Sciences
Cardiac arrest is a serious medical condition wherein there is abrupt loss of heart function, breathing and consciousness. The condition usually results from an electrical disturbance in the ...
Report Code : A08079 | Category : Life Sciences
Report Overview The report covers exhaustive analysis of global Cardiac resynchronization therapy market in terms of qualitative and quantitative aspects. The report provides in-depth information on market size & forecast, current market trend
Report Code : A08080 | Category : Life Sciences
Cardiac catheters is device which is widely used in cardiac catheterization, angioplasty, Percutaneous Coronary Intervention (PCI), and other interventional procedures. In the cardiac catheter helps to measuring heart ...
Report Code : A10387 | Category : Life Sciences
The global cardiac mapping market was valued at $2.6 billion in 2021, and is projected to reach $4.6 billion by 2031, growing at a CAGR of 5.7% from 2022 to 2031.
Report Code : A10920 | Pages : 310 | Category : Life Sciences
An artificial heart valve or cardiac valve is a one-way valve implanted into the heart of a patient to replace a dysfunctional native heart valve (valvular heart disease). ...
Report Code : A11126 | Category : Life Sciences
The global cardiac rehabilitation market was valued at $1.97 billion in 2021, and is projected to reach $3.24 billion by 2031, growing at a CAGR of 5.1% from 2022 to 2031.
Report Code : A11270 | Pages : 269 | Category : Life Sciences
Cardiac surgery instruments are referred to as the instruments used in the procedure of cardiovascular surgery. It is the surgery performed on the heart by the cardiac surgeons. ...
Report Code : A11498 | Category : Life Sciences
A range of treatments have been developed for the management of cardiac arrhythmias. These include antiarrhythmic drugs, artificial pacemakers, implanted cardiac defibrillators and ablation of damaged or malfunctioning ...
Report Code : A11909 | Category : Life Sciences
Cardiopulmonary exercise testing is a comparably non-invasive procedure of testing that measures respiratory gas exchange such as oxygen uptake, carbon dioxide, minute ventilation, and anaerobic threshold. Moreover, electrocardiography, ...
Report Code : A13189 | Category : Life Sciences
The global cardiac patch monitor market was valued at $504 million in 2022, and is projected to reach $3126.1 million by 2032, growing at a CAGR of 20% from 2023 to 2032.
Report Code : A14020 | Pages : 177 | Category : Life Sciences
Global cardiovascular diagnostic testing market was valued at $6,876.29 million in 2020, and is projected to reach $15,430.46 million by 2030, registering a CAGR of 8.3% from 2021 ...
Report Code : A14287 | Pages : 205 | Category : Life Sciences
Global Cardiac Biomarkers Market is expected to garner $2,085.9 million by 2020, registering a CAGR of 18.9% during the forecast period 2015-2020. The prevention of cardiac diseases by ...
Report Code : A00219 | Pages : 103 | Category : Life Sciences
The global cardiovascular ultrasound market was valued at $2.4 billion in 2022, and is projected to reach $4.2 billion by 2032, growing at a CAGR of 5.8% from 2023 to 2032.
Report Code : A02492 | Pages : 464 | Category : Life Sciences
The global cardiovascular prosthetic devices market was valued at $26,937.8 million in 2021 and is estimated to reach $61,469.8 million by 2031, growing at a CAGR of 8.6% from 2022 to 2031.
Report Code : A01293 | Pages : 248 | Category : Life Sciences
The global cardiac care medical equipment market was valued at $50.8 billion in 2023, and is projected to reach $102.2 billion by 2033, growing at a CAGR of 7.3% from 2024 to 2033.
Report Code : A324387 | Pages : 280 | Category : Life Sciences
The global cardiac monitoring products market was valued at $25.1 billion in 2023, and is projected to reach $42.2 billion by 2033, growing at a CAGR of 5.3% from 2024 to 2033.
Report Code : A324071 | Pages : 280 | Category : Life Sciences
The global cardiac ablation market was valued at $3.6 billion in 2023, and is projected to reach $8.6 billion by 2033, growing at a CAGR of 9.9% from 2024 to 2033.
Report Code : A296512 | Pages : 315 | Category : Life Sciences
The global card payments market was valued at $28.6 trillion in 2023, and is projected to reach $56.4 trillion by 2033, growing at a CAGR of 6.9% from 2024 to 2033.
Report Code : A324247 | Pages : 300 | Category : BFSI
The anti-obesity drugs market was valued at $1,605.36 million in 2022 and is estimated to reach $4,439.34 million by 2032, exhibiting a CAGR of 10.7% from 2023 to 2032.
Report Code : A03823 | Pages : 447 | Category : Life Sciences
The global vital organs support systems and medical bionics market size in 2017 was $28,169 million, and is projected to reach $59,412 million by 2025, growing at a CAGR of 9.9% from 2018 to 2025.
Report Code : A04920 | Pages : 293 | Category : Life Sciences
Blood transfusion is a process of transferring of blood or blood components from a donor to a receiver intravenously.
Report Code : A04923 | Pages : 250 | Category : Life Sciences
The biomarker technologies market accounted for $21,594 million in 2018, and is expected to reach $58,508 million by 2026, registering a CAGR of 13.2% from 2019 to 2026.
Report Code : A04930 | Pages : 255 | Category : Life Sciences
